Research Output per year
Fingerprint Dive into the research topics where Michele Cilli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Neuroblastoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Growth
Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Heterografts
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Therapeutic Uses
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1989 2019
- 3714 Citations
- 34 h-Index
- 118 Article
Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity
Viale, M., Vecchio, G., Monticone, M., Bertone, V., Giglio, V., Maric, I., Cilli, M., Bocchini, V., Profumo, A., Ponzoni, M., Emionite, L. & Rocco, M., Aug 1 2019, In : Pharmaceutical Research. 36, 8, 115.Research output: Contribution to journal › Article
Cyclodextrins
Fibrin
Neuroblastoma
Doxorubicin
Toxicity
1
Citation
(Scopus)
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β
Rossi, M., Bucci, G., Rizzotto, D., Bordo, D., Marzi, M. J., Puppo, M., Flinois, A., Spadaro, D., Citi, S., Emionite, L., Cilli, M., Nicassio, F., Inga, A., Briata, P. & Gherzi, R., Dec 1 2019, In : Nature Communications. 10, 1, 1969.Research output: Contribution to journal › Article
Open Access
regulators
RNA Stability
Transcription
Epithelial Cells
Messenger RNA
4
Citations
(Scopus)
A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy
Sidarovich, V., De Mariano, M., Aveic, S., Pancher, M., Adami, V., Gatto, P., Pizzini, S., Pasini, L., Croce, M., Parodi, F., Cimmino, F., Avitabile, M., Emionite, L., Cilli, M., Ferrini, S., Pagano, A., Capasso, M., Quattrone, A., Tonini, G. P. & Longo, L., Jul 1 2018, In : Molecular Cancer Therapeutics. 17, 7, p. 1405-1415 11 p.Research output: Contribution to journal › Article
Neuroblastoma
Protein-Tyrosine Kinases
Therapeutics
Pharmaceutical Preparations
Libraries
3
Citations
(Scopus)
Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations
Viale, M., Monticone, M., Maric, I., Giglio, V., Profumo, A., Aprile, A., Cilli, M., Abelmoschi, M. L. & Rocco, M., Aug 1 2018, In : Pharmacological Reports. 70, 4, p. 760-765 6 p.Research output: Contribution to journal › Article
Fibrin
Doxorubicin
Gels
Pharmaceutical Preparations
Thrombin
3
Citations
(Scopus)
CHL1 gene acts as a tumor suppressor in human neuroblastoma
Ognibene, M., Pagnan, G., Marimpietri, D., Cangelosi, D., Cilli, M., Benedetti, M. C., Boldrini, R., Garaventa, A., Frassoni, F., Eva, A., Varesio, L., Pistoia, V. & Pezzolo, A., Jan 1 2018, In : Oncotarget. 9, 40, p. 25903-25921 19 p.Research output: Contribution to journal › Article
Neuroblastoma
Genes
Neoplasms
Heterografts
Neuronal Cell Adhesion Molecules